Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMA compared with ELDN: revenue, margins and what each company keeps, and the suppliers and customers both name
IMA
ImageneBio, Inc.
Change
Mkt cap
Revenue
Revenue
ELDN
Eledon Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMA
ImageneBio, Inc.
vs
ELDN
Eledon Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IMA
3
—
Hutchmed
unlisted
supplier
—
Wuxi Biologics
unlisted
supplier
—
WuXi Biologics (Hong Kong)
unlisted
supplier
Shared
0
No shared counterparties.
Only ELDN
1
NCEL
NewcelX
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
IMA
ImageneBio, Inc.
Change
4.10
▼
−0.07%
· post 4.10
Mkt cap
$46.5M
Revenue
$800,000
Q4 FY25
ELDN
Eledon Pharmaceuticals, Inc.
Change
2.75
▼
−0.62%
· post 2.63
Closed
Nov 2 '26
Mkt cap
$225.1M
Revenue
—
vs
Compare
Closed
Nov 2 '26
IMA
ImageneBio, Inc.
vs
ELDN
Eledon Pharmaceuticals, Inc.
4.10
▼
−0.07%
post 4.10
Price
2.75
▼
−0.62%
post 2.63
$46.5M
Mkt cap
$225.1M
Q4 FY25
$800,000
Revenue
—
Change
Change
IMA
4.10
▼
−0.07%
vs
ELDN
2.75
▼
−0.62%
Closed
Nov 2 '26